vs

Side-by-side financial comparison of HARROW, INC. (HROW) and S&T BANCORP INC (STBA). Click either name above to swap in a different company.

S&T BANCORP INC is the larger business by last-quarter revenue ($102.1M vs $89.1M, roughly 1.1× HARROW, INC.). S&T BANCORP INC runs the higher net margin — 34.4% vs 7.4%, a 26.9% gap on every dollar of revenue. Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 2.6%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

HROW vs STBA — Head-to-Head

Bigger by revenue
STBA
STBA
1.1× larger
STBA
$102.1M
$89.1M
HROW
Higher net margin
STBA
STBA
26.9% more per $
STBA
34.4%
7.4%
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
2.6%
STBA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HROW
HROW
STBA
STBA
Revenue
$89.1M
$102.1M
Net Profit
$6.6M
$35.1M
Gross Margin
79.3%
Operating Margin
17.5%
Net Margin
7.4%
34.4%
Revenue YoY
33.3%
Net Profit YoY
-2.2%
5.0%
EPS (diluted)
$0.20
$0.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
STBA
STBA
Q1 26
$102.1M
Q4 25
$89.1M
$105.3M
Q3 25
$71.6M
$103.0M
Q2 25
$63.7M
$100.1M
Q1 25
$47.8M
$93.8M
Q4 24
$66.8M
$94.3M
Q3 24
$49.3M
$96.4M
Q2 24
$48.9M
$96.9M
Net Profit
HROW
HROW
STBA
STBA
Q1 26
$35.1M
Q4 25
$6.6M
$34.0M
Q3 25
$1.0M
$35.0M
Q2 25
$5.0M
$31.9M
Q1 25
$-17.8M
$33.4M
Q4 24
$6.8M
$33.1M
Q3 24
$-4.2M
$32.6M
Q2 24
$-6.5M
$34.4M
Gross Margin
HROW
HROW
STBA
STBA
Q1 26
Q4 25
79.3%
Q3 25
75.3%
Q2 25
74.5%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Operating Margin
HROW
HROW
STBA
STBA
Q1 26
Q4 25
17.5%
40.3%
Q3 25
20.6%
42.6%
Q2 25
17.9%
40.0%
Q1 25
-23.5%
44.5%
Q4 24
19.3%
43.8%
Q3 24
2.7%
43.0%
Q2 24
3.1%
44.2%
Net Margin
HROW
HROW
STBA
STBA
Q1 26
34.4%
Q4 25
7.4%
32.3%
Q3 25
1.4%
33.9%
Q2 25
7.8%
31.9%
Q1 25
-37.2%
35.6%
Q4 24
10.1%
35.1%
Q3 24
-8.6%
33.8%
Q2 24
-13.2%
35.5%
EPS (diluted)
HROW
HROW
STBA
STBA
Q1 26
$0.94
Q4 25
$0.20
$0.88
Q3 25
$0.03
$0.91
Q2 25
$0.13
$0.83
Q1 25
$-0.50
$0.87
Q4 24
$0.19
$0.86
Q3 24
$-0.12
$0.85
Q2 24
$-0.18
$0.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
STBA
STBA
Cash + ST InvestmentsLiquidity on hand
$72.9M
Total DebtLower is stronger
$250.0M
$100.8M
Stockholders' EquityBook value
$52.4M
$1.4B
Total Assets
$399.5M
$9.9B
Debt / EquityLower = less leverage
4.77×
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
STBA
STBA
Q1 26
Q4 25
$72.9M
$163.4M
Q3 25
$74.3M
$196.2M
Q2 25
$53.0M
$203.1M
Q1 25
$66.7M
$211.8M
Q4 24
$47.2M
$244.8M
Q3 24
$72.6M
$228.1M
Q2 24
$71.0M
$246.3M
Total Debt
HROW
HROW
STBA
STBA
Q1 26
$100.8M
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Stockholders' Equity
HROW
HROW
STBA
STBA
Q1 26
$1.4B
Q4 25
$52.4M
$1.5B
Q3 25
$47.0M
$1.5B
Q2 25
$49.7M
$1.4B
Q1 25
$56.5M
$1.4B
Q4 24
$69.7M
$1.4B
Q3 24
$58.0M
$1.4B
Q2 24
$58.5M
$1.3B
Total Assets
HROW
HROW
STBA
STBA
Q1 26
$9.9B
Q4 25
$399.5M
$9.9B
Q3 25
$363.1M
$9.8B
Q2 25
$345.0M
$9.8B
Q1 25
$364.2M
$9.7B
Q4 24
$389.0M
$9.7B
Q3 24
$351.5M
$9.6B
Q2 24
$306.6M
$9.6B
Debt / Equity
HROW
HROW
STBA
STBA
Q1 26
0.07×
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
STBA
STBA
Operating Cash FlowLast quarter
$8.4M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
STBA
STBA
Q1 26
Q4 25
$8.4M
$133.6M
Q3 25
$16.6M
$40.5M
Q2 25
$-803.0K
$28.3M
Q1 25
$19.7M
$28.7M
Q4 24
$-17.8M
$173.4M
Q3 24
$3.0M
$27.6M
Q2 24
$-2.7M
$44.7M
Free Cash Flow
HROW
HROW
STBA
STBA
Q1 26
Q4 25
$8.1M
$128.8M
Q3 25
$16.4M
$39.9M
Q2 25
$-969.0K
$27.1M
Q1 25
$19.5M
$27.0M
Q4 24
$-18.3M
$170.4M
Q3 24
$2.3M
$26.9M
Q2 24
$-3.1M
$43.9M
FCF Margin
HROW
HROW
STBA
STBA
Q1 26
Q4 25
9.1%
122.4%
Q3 25
22.9%
38.7%
Q2 25
-1.5%
27.1%
Q1 25
40.8%
28.8%
Q4 24
-27.4%
180.7%
Q3 24
4.8%
28.0%
Q2 24
-6.3%
45.3%
Capex Intensity
HROW
HROW
STBA
STBA
Q1 26
Q4 25
0.4%
4.5%
Q3 25
0.3%
0.6%
Q2 25
0.3%
1.2%
Q1 25
0.4%
1.8%
Q4 24
0.8%
3.1%
Q3 24
1.2%
0.7%
Q2 24
0.7%
0.9%
Cash Conversion
HROW
HROW
STBA
STBA
Q1 26
Q4 25
1.27×
3.93×
Q3 25
16.26×
1.16×
Q2 25
-0.16×
0.89×
Q1 25
0.86×
Q4 24
-2.62×
5.24×
Q3 24
0.85×
Q2 24
1.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

STBA
STBA

Net Interest Income$88.4M87%
Noninterest Income$13.6M13%

Related Comparisons